IP Library › Assignment 028234/0424
Patent Assignment
Reel/Frame 028234/0424

Security Agreement

Recorded: 2012-05-18 Pages: 88
Assignors
PRECISION DERMATOLOGY, INC.
Executed: 2012-04-25
ONSET DERMATOLOGICS, LLC
Executed: 2012-04-25
PROSKIN LLC
Executed: 2012-04-25
PRECISION MD LLC
Executed: 2012-04-25
TP CREAM SUB, LLC
Executed: 2012-04-25
TP LOTION SUB, LLC
Executed: 2012-04-25
Assignee
MIDCAP FUNDING III, LLC
7255 WOODMONT AVENUE, SUITE 200, BETHESDA, MARYLAND, 20814
Covered Properties (36)
Modulation of Zinc Levels to Improve Tissue Properties
Non-Flammable Topical Anesthetic Liquid Aerosols
Topical Aerosol Foams
Compositions for Topical Enzymatic Debridement
Skin Treatment Educational Kit
Topical Delivery with a Carrier Fluid
Topical Pharmaceutical Foam Composition
Foamable Benzoyl Peroxide Compositions for Topical Administration
Foamable Microemulsion Compositions for Topical Administration
Emollient Foams for Treatment of Dermatoses
Stable Aerosol Topical Foams Comprising a Hypochlorite Salt
Emollient Foams for Treatment of Seborrheic Dermatitis
High Oil-Content Emollient Aerosol Foam Compositions
Aerosol Foams Comprising Clindamycin Phosphate
Modulation of Zinc Levels to Improve Tissue Properties
Patent: 8,975,295 →
Application: 10/692,191 →
Publication: US 2004/0157921
Stabilized Steroid Composition and Method for Its Preparation
Patent: 7,378,405 →
Application: 10/762,652 →
Publication: US 2004/0152682
Non-flammable topical anesthetic liquid aerosols
Application: 10/956,819 →
Publication: US 2005/0123484
Skin treatment educational kit
Application: 11/418,514 →
Publication: US 2007/0166273
Stabilized Steroid Composition and Method for Its Preparation
Patent: 7,981,877 →
Application: 11/432,742 →
Publication: US 2006/0205703
7-Dimethylamino-6-Demethyl-6-Deoxytetracycline Skin Treatment Kit
Application: 11/459,778 →
Publication: US 2007/0166274
Topical Delivery with a Carrier Fluid
Application: 11/464,100 →
Publication: US 2007/0036731
Topical Pharmaceutical Foam Composition
Application: 11/552,457 →
Publication: US 2007/0154402
Foamable Microemulsion Compositions for Topical Administration
Patent: 8,652,443 →
Application: 12/371,155 →
Publication: US 2009/0232743
Foamable Benzoyl Peroxide Compositions for Topical Administration
Application: 12/546,189 →
Publication: US 2010/0202978
Emollient Foams for Treatment of Dermatoses
Application: 12/713,379 →
Publication: US 2011/0212035
Stabilized Steroid Composition and Method for its Preparation
Patent: 8,546,364 →
Application: 12/840,487 →
Publication: US 2010/0286108
Stable Aerosol Topical Foams Comprising a Hypochlorite Salt
Application: 12/872,566 →
Publication: US 2011/0052506
Emollient Foams for Treatment of Seborrheic Dermatitis
Patent: 8,623,330 →
Application: 13/017,204 →
Publication: US 2011/0229417
High Oil-Content Emollient Aerosol Foam Compositions
Patent: 8,784,780 →
Application: 13/046,088 →
Publication: US 2011/0305643
Aerosol Foams Comprising Clindamycin Phosphate
Patent: 8,592,380 →
Application: 13/053,524 →
Publication: US 2011/0236321
Stabilized Steroid Composition and Method for Its Preparation
Patent: 8,389,502 →
Application: 13/155,493 →
Publication: US 2011/0237811
Method and System for Automatic Product Replenishment
Application: 13/249,960 →
Publication: US 2013/0085957
Tandem Hypochlorite-Barrier Repair Therapy for the Treatment of Eczema
Application: 13/313,468 →
Publication: US 2012/0148516
Topical Pharmaceutical Foam Composition
Application: 13/343,906 →
Publication: US 2012/0128598
Topical Delivery with a Carrier Fluid
Application: 13/409,608 →
Publication: US 2012/0189557
Stable Dermatological Aerosol Foams Utilizing Reactive Propellants
Application: 61/555,045 →
Related Assignments (25)
Other recorded transfers of the patents in this record — the chain of ownership.
Release of Security Interest Apr 26, 2012
From: LAMINAR DIRECT CAPITAL, L.L.C. AS SUCCESSOR IN INTEREST TO LAMINAR DIRECT CAPITAL, L.P.
To: TRIAX PHARMACEUTICALS, LLC
Reel/Frame 028114/0337 →
Assignment of Assignor's Interest Aug 22, 2012
From: FERNDALE LABORATORIES, INC.
To: TRIAX PHARMACEUTICALS, LLC
Reel/Frame 028828/0984 →
Assignment of Assignor's Interest Aug 22, 2012
From: FERNDALE IP, INC.
To: TRIAX PHARMACEUTICALS, LLC
Reel/Frame 028828/0702 →
Assignment of Assignor's Interest Aug 22, 2012
From: PATEL, PRAVIN M.
To: FERNDALE IP, INC.
Reel/Frame 028828/0674 →
Assignment of Assignor's Interest Aug 22, 2012
From: TRIAX PHARMACEUTICALS, LLC
To: PRECISION DERMATOLOGY, INC.
Reel/Frame 028828/0598 →
Assignment of Assignor's Interest Sep 28, 2012
From: REVANCE THERAPEUTICS, INC.
To: PRECISION DERMATOLOGY, INC.
Reel/Frame 029043/0761 →
Release of Security Interest Sep 11, 2013
From: FERNDALE LABORATORIES, INC.
To: PRECISION DERMATOLOGY, INC.
Reel/Frame 031184/0126 →
Security Agreement Sep 20, 2013
From: PRECISION DERMATOLOGY, INC.
To: GCI CAPITAL MARKETS LLC
Reel/Frame 031249/0011 →
Release of Security Interest Sep 27, 2013
From: MIDCAP FUNDING III, LLC
To: PRECISION DERMATOLOGY COMPANY, INC.; ONSET DERMATOLOGICS, LLC; PROSKIN, LLC; PRECISION MD, LLC
Reel/Frame 031296/0492 →
Corrective Assignment to Correct the Release of Secured Party Previously Recorded on Reel 013384 Frame 0126. Assignor(S) Hereby Confirms the Correction of Doc Date from 4-25-2012 to 9-9-2013. Oct 29, 2013
From: FERNDALE LABORATORIES, INC.
To: PRECISION DERMATOLOGY, INC.
Reel/Frame 031509/0788 →
Release of Security Interest Jul 7, 2014
From: GCI CAPITAL MARKETS, LLC
To: PRECISION DERMATOLOGY, INC.
Reel/Frame 033280/0556 →
Security Interest May 20, 2015
From: ENCORE DERMATOLOGY, INC.
To: VALEANT PHARMACEUTICALS INTERNATIONAL, INC.
Reel/Frame 035681/0733 →
Security Agreement Jul 6, 2015
From: ECR PHARMACEUTICALS CO., INC.; PRECISION DERMATOLOGY, INC.
To: BARCLAYS BANK PLC, AS COLLATERAL AGENT
Reel/Frame 036091/0257 →
Assignment of Assignor's Interest Aug 26, 2015
From: VALEANT PHARMACEUTICALS NORTH AMERICA LLC; PRECISION DERMATOLOGY, INC.; VALEANT PHARMACEUTICALS IRELAND; VALEANT PHARMACEUTICALS LUXEMBOURG S.A R.L.
To: ENCORE DERMATOLOGY, INC.
Reel/Frame 036428/0744 →
Security Interest Jul 19, 2017
From: PRECISION DERMATOLOGY, INC.
To: THE BANK OF NEW YORK MELLON
Reel/Frame 043041/0864 →
Security Interest Feb 26, 2018
From: ATON PHARMA, INC.; BAUSCH & LOMB INCORPORATED; BAUSCH & LOMB PHARMA HOLDINGS CORP.; COMMONWEALTH LABORATORIES, LLC
To: THE BANK OF NEW YORK MELLON, AS COLLATERAL AGENT
Reel/Frame 045444/0634 →
Security Interest Feb 26, 2018
From: ATON PHARMA, INC.; BAUSCH & LOMB INCORPORATED; BAUSCH & LOMB PHARMA HOLDINGS CORP.; COMMONWEALTH LABORATORIES, LLC
To: BARCLAYS BANK PLC, AS COLLATERAL AGENT
Reel/Frame 045444/0299 →
Security Interest Mar 11, 2019
From: BAUSCH HEALTH AMERICAS, INC.; BAUSCH & LOMB INCORPORATED; BAUSCH HEALTH US, LLC; SOLTA MEDICAL, INC.
To: THE BANK OF NEW YORK MELLON, AS NOTES COLLATERAL AGENT
Reel/Frame 048556/0758 →
Intellectual Property Security Agreement Jul 3, 2019
From: BAUSCH HEALTH IRELAND LIMITED; BAUSCH HEALTH COMPANIES INC.; BAUSCH HEALTH, CANADA INC.; TECHNOLAS PERFECT VISION GMBH
To: THE BANK OF NEW YORK MELLON, AS COLLATERAL AGENT
Reel/Frame 049672/0652 →
Security Interest Jun 8, 2021
From: BAUSCH & LOMB INCORPORATED; BAUSCH HEALTH US, LLC; SOLTA MEDICAL, INC.; MEDICIS PHARMACEUTICAL CORPORATION
To: THE BANK OF NEW YORK MELLON, AS NOTES COLLATERAL AGENT
Reel/Frame 056811/0814 →
Security Agreement Feb 10, 2022
From: BAUSCH & LOMB INCORPORATED; BAUSCH HEALTH US, LLC; SOLTA MEDICAL, INC.; MEDICIS PHARMACEUTICAL CORPORATION
To: THE BANK OF NEW YORK MELLON
Reel/Frame 059121/0001 →
Security Agreement (First Lien) Oct 4, 2022
From: BAUSCH HEALTH US, LLC; BAUSCH HEALTH AMERICAS, INC.; MEDICIS PHARMACEUTICAL CORPORATION; ORAPHARMA, INC.
To: THE BANK OF NEW YORK MELLON, AS NOTES COLLATERAL AGENT
Reel/Frame 061595/0066 →
Security Agreement (Second Lien) Oct 5, 2022
From: BAUSCH HEALTH US, LLC; BAUSCH HEALTH AMERICAS, INC.; MEDICIS PHARMACEUTICAL CORPORATION; ORAPHARMA, INC.
To: THE BANK OF NEW YORK MELLON, AS NOTES COLLATERAL AGENT
Reel/Frame 061606/0468 →
Release of Security Interest Apr 8, 2025
From: BARCLAYS BANK PLC, AS COLLATERAL AGENT
To: SOLTA MEDICAL, INC.; PRECISION DERMATOLOGY, INC.; BAUSCH HEALTH IRELAND LIMITED (F/K/A/ VALEANT PHARMACEUTICALS IRELAND LIMITED); SALIX PHARMACEUTICALS, INC.
Reel/Frame 070778/0199 →
U.S. Patent Security Agreement Jun 13, 2025
From: MEDICIS PHARMACEUTICAL CORPORATION; ORAPHARMA, INC.; BAUSCH HEALTH US, LLC (F/K/A VALEANT PHARMACEUTICALS NORTH AMERICA LLC); PRECISION DERMATOLOGY, INC.
To: JPMORGAN CHASE BANK, N.A.
Reel/Frame 071566/0200 →